CATALOGO DEI PRODOTTI DELLA RICERCA

Merz, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.789
NA - Nord America 1.772
AS - Asia 1.237
SA - Sud America 153
AF - Africa 41
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.731
RU - Federazione Russa 773
SG - Singapore 448
CN - Cina 367
IT - Italia 266
DE - Germania 174
GB - Regno Unito 153
VN - Vietnam 139
BR - Brasile 123
HK - Hong Kong 113
IE - Irlanda 85
FR - Francia 82
SE - Svezia 82
FI - Finlandia 62
KR - Corea 38
CA - Canada 32
IN - India 28
NL - Olanda 26
JP - Giappone 19
BD - Bangladesh 16
AT - Austria 15
UA - Ucraina 15
AR - Argentina 13
TR - Turchia 12
ES - Italia 11
ID - Indonesia 9
PL - Polonia 9
ZA - Sudafrica 9
BJ - Benin 8
NG - Nigeria 8
TG - Togo 8
IQ - Iraq 7
SA - Arabia Saudita 7
AU - Australia 5
CZ - Repubblica Ceca 5
BE - Belgio 4
CH - Svizzera 4
JO - Giordania 4
LT - Lituania 4
MX - Messico 4
DZ - Algeria 3
EC - Ecuador 3
LB - Libano 3
NO - Norvegia 3
PE - Perù 3
PK - Pakistan 3
PT - Portogallo 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
NP - Nepal 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.998
Salva come PNG Salva come JPEG
Città #
Moscow 312
Ashburn 299
Dallas 261
Singapore 259
Chandler 181
San Jose 166
Hong Kong 111
Southend 91
Dublin 86
Verona 74
The Dalles 65
Munich 63
Beijing 62
Ho Chi Minh City 52
Los Angeles 44
New York 38
Woodbridge 33
Jacksonville 32
Helsinki 30
Turku 25
Hanoi 24
Jinan 23
São Paulo 21
Lawrence 20
London 20
Princeton 20
Tianjin 20
Buffalo 19
Milan 19
Wilmington 19
Frankfurt am Main 18
Rome 18
Orem 15
Tokyo 15
Taiyuan 14
Toronto 14
Atlanta 13
Santa Clara 13
Columbus 12
Montreal 12
Sindelfingen 12
Changsha 11
Seattle 11
Amsterdam 10
Da Nang 10
Denver 10
Kent 10
Shenyang 10
Haikou 9
Nuremberg 9
Redondo Beach 9
Stockholm 9
Washington 9
Barnet 8
Chicago 8
Cotonou 8
Hebei 8
Houston 8
Lomé 8
Marseille 8
Redwood City 8
Taizhou 8
Abuja 7
Council Bluffs 7
Hangzhou 7
Jakarta 7
Johannesburg 7
Monza 7
Phoenix 7
Vienna 7
Warsaw 7
Bologna 6
Chennai 6
Madrid 6
Nanchang 6
Nanjing 6
Ningbo 6
Paris 6
Rio de Janeiro 6
Ann Arbor 5
Boston 5
City of London 5
Fairfield 5
Fuzhou 5
Guangzhou 5
Jiaxing 5
Nürnberg 5
Riyadh 5
San Francisco 5
Seoul 5
Treviso 5
Amman 4
Brasília 4
Dhaka 4
Lappeenranta 4
Mumbai 4
Redmond 4
Turin 4
Zhengzhou 4
Zurich 4
Totale 3.041
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 315
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 285
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 249
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 234
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 203
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 198
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 192
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 183
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 175
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 174
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 173
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 162
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 156
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 155
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 147
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 145
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 141
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 136
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 134
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 133
Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience 132
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 119
Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer 114
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 113
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 109
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 104
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 100
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 85
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 84
Perioperative NALIRIFOX in Patients with Resectable Pancreatic Ductal Adenocarcinoma: An Updated Analysis of Survival and Response Biomarkers from the Phase II nITRO Trial. 84
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study 84
Totale 5.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.987
article - articoli 16.852
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 135
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 11 10
2021/2022222 16 87 8 17 1 5 1 13 6 3 11 54
2022/2023492 25 67 34 79 38 130 3 26 64 8 12 6
2023/2024423 7 25 28 34 33 66 69 37 9 23 76 16
2024/2025816 40 37 38 127 30 34 62 40 86 42 112 168
2025/20262.626 144 114 256 413 670 187 268 123 227 181 43 0
Totale 5.050